The present analysis with more than 3000 acute ischemic stroke patients showed that having elevated SDF-1 levels at baseline was not associated with an increased risk of recurrent stroke as well as cardiovascular events after ischemic stroke. This evidence concerns the gene CXCL12 and Stroke.